Heme oxygenase-1 plays a pro-life role in experimental brain stem death via nitric oxide synthase I/protein kinase G signaling at rostral ventrolateral medulla.
BACKGROUND
Despite its clinical importance, a dearth of information exists on the cellular and molecular mechanisms that underpin brain stem death. A suitable neural substrate for mechanistic delineation on brain stem death resides in the rostral ventrolateral medulla (RVLM) because it is the origin of a life-and-death signal that sequentially increases (pro-life) and decreases (pro-death) to reflect the advancing central cardiovascular regulatory dysfunction during the progression towards brain stem death in critically ill patients. The present study evaluated the hypothesis that heme oxygnase-1 (HO-1) may play a pro-life role as an interposing signal between hypoxia-inducible factor-1 (HIF-1) and nitric oxide synthase I (NOS I)/protein kinase G (PKG) cascade in RVLM, which sustains central cardiovascular regulatory functions during brain stem death.


METHODS
We performed cardiovascular, pharmacological, biochemical and confocal microscopy experiments in conjunction with an experimental model of brain stem death that employed microinjection of the organophosphate insecticide mevinphos (Mev; 10 nmol) bilaterally into RVLM of adult male Sprague-Dawley rats.


RESULTS
Western blot analysis coupled with laser scanning confocal microscopy revealed that augmented HO-1 expression that was confined to the cytoplasm of RVLM neurons occurred preferentially during the pro-life phase of experimental brain stem death and was antagonized by immunoneutralization of HIF-1α or HIF-1β in RVLM. On the other hand, the cytoplasmic presence of HO-2 in RVLM neurons manifested insignificant changes during both phases. Furthermore, immunoneutralization of HO-1 or knockdown of ho-1 gene in RVLM blunted the augmented life-and-death signals exhibited during the pro-life phase. Those pretreatments also blocked the upregulated pro-life NOS I/PKG signaling without affecting the pro-death NOS II/peroxynitrite cascade in RVLM.


CONCLUSIONS
We conclude that transcriptional upregulation of HO-1 on activation by HIF-1 in RVLM plays a preferential pro-life role by sustaining central cardiovascular regulatory functions during brain stem death via upregulation of NOS I/PKG signaling pathway. Our results further showed that the pro-dead NOS II/peroxynitrite cascade in RVLM is not included in this repertoire of cellular events.
Dai
Kuang-Yu
KY
Center for Translational Research in Biomedical Sciences, Chang Gung Memorial, Hospital-Kaohsiung Medical Center, Kaohsiung County 83301, Taiwan.
Chan
Samuel Hh
SH
Chang
Alice Yw
AY
D000704:Analysis of Variance; D000818:Animals; D015153:Blotting, Western; D001926:Brain Death / Q000378:metabolism / Q000503:physiopathology*; D017869:Cyclic GMP-Dependent Protein Kinases / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D055785:Gene Knockdown Techniques; D051547:Heme Oxygenase-1 / Q000235:genetics / Q000378:metabolism*; D007306:Insecticides / Q000008:administration & dosage / Q000633:toxicity*; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D008526:Medulla Oblongata / Q000166:cytology / Q000187:drug effects*; D008799:Mevinphos / Q000008:administration & dosage / Q000633:toxicity*; D018613:Microscopy, Confocal; D024101:Mitochondrial Proteins; D009363:Neoplasm Proteins / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D009841:Oligonucleotides / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000502:physiology*
C405619:HIGD1A protein, human; D007306:Insecticides; D047908:Intracellular Signaling Peptides and Proteins; D024101:Mitochondrial Proteins; D009363:Neoplasm Proteins; D009841:Oligonucleotides; D008799:Mevinphos; D052248:Nitric Oxide Synthase Type I; D051547:Heme Oxygenase-1; D017869:Cyclic GMP-Dependent Protein Kinases
Shock. 2001 Jan;15(1):35-41
11198355
Gastroenterology. 2008 Dec;135(6):2055-64, 2064.e1-2
18926825
Am J Physiol. 1997 Jan;272(1 Pt 2):H485-92
9038971
Circ Res. 2000 Feb 18;86(3):319-25
10679484
Mol Cells. 2000 Oct 31;10(5):566-74
11101149
Shock. 2004 Apr;21(4):358-63
15179137
Biochem Biophys Res Commun. 2007 Aug 31;360(3):646-52
17610843
EMBO J. 1999 Apr 1;18(7):1905-14
10202154
J Neurochem. 2006 Aug;98(4):1200-16
16787408
Crit Care Med. 2000 Aug;28(8):2805-11
10966254
Cell. 2007 Oct 19;131(2):309-23
17956732
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4
7539918
Am J Physiol. 1993 Jun;264(6 Pt 2):H2208-13
8322952
Biochem Biophys Res Commun. 2004 Nov 5;324(1):394-400
15465032
Cell. 2007 Nov 2;131(3):584-95
17981124
Am J Physiol. 1998 Feb;274(2):L212-9
9486205
Br Med J. 1979 Feb 3;1(6159):332
421104
Am J Physiol Renal Physiol. 2001 Nov;281(5):F900-8
11592948
Br Med J (Clin Res Ed). 1983 Jan 1;286(6358):39
6401455
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):75-80
7823073
Prog Neurobiol. 2005 Dec;77(6):396-425
16376477
Eur J Neurosci. 2003 Jun;17(11):2249-55
12814358
J Physiol. 2007 Jun 15;581(Pt 3):1293-307
17395621
J Exp Med. 1995 Dec 1;182(6):1683-93
7500013
Biochem Cell Biol. 2005 Oct;83(5):597-607
16234848
J Physiol. 1994 Jan 1;474(1):1-19
8014887
Am J Respir Cell Mol Biol. 1996 Jul;15(1):9-19
8679227
Neuropharmacology. 2004 Jun;46(8):1184-94
15111025
Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R403-14
16973934
J Interferon Cytokine Res. 2005 Jun;25(6):297-310
15957953
Shock. 2009 Dec;32(6):651-8
19333137
Antioxid Redox Signal. 2007 Dec;9(12):2209-25
17887916
Br Med J. 1976 Nov 13;2(6045):1187-8
990836
J Pharmacol Exp Ther. 1995 Dec;275(3):1568-74
8531130
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5364-74
19474404
J Clin Invest. 2001 May;107(9):1163-71
11342580
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):10996-1002
11572959
J Neurochem. 1999 Mar;72(3):1187-203
10037492
J Biol Chem. 1997 Feb 28;272(9):5375-81
9038135
Am J Physiol. 1997 Sep;273(3 Pt 2):H1291-8
9321818
Cell Stress Chaperones. 2005 Spring;10(1):17-23
15832944
Crit Care Med. 1997 Feb;25(2):258-66
9034261
J Biol Chem. 2007 Feb 16;282(7):4585-4600
17150954
Physiol Rev. 2006 Apr;86(2):583-650
16601269
J Neurochem. 2004 Jul;90(2):368-78
15228594
JAMA. 1981 Nov 13;246(19):2184-6
7289009
Neuropharmacology. 2005 Jan;48(1):161-72
15617736
J Neurol. 1999 Jun;246(6):432-7
10431766
Shock. 2005 Apr;23(4):353-9
15803059